Free Republic
Browse · Search
General/Chat
Topics · Post Article

To: SeekAndFind

Here’s what Pfizer based the 91.3% figure on:

Of the 927 cases of symptomatic Covid-19 observed through March 13, 850 were in people who received a placebo and 77 in people who were vaccinated.

That corresponds to a vaccine efficacy of 91.3% up to six months after getting the second dose, Pfizer and BioNTech said.

The protection remained generally consistent across age, gender, race and ethnicity, as well as among individuals with underlying health conditions, the companies said.


2 posted on 04/02/2021 8:20:28 AM PDT by SeekAndFind
[ Post Reply | Private Reply | To 1 | View Replies ]


To: SeekAndFind

Here’s my bottom line concern:

It’s important to discover how long these vaccines can maintain their potency. Is it possible that they would work like a measles vaccine and last a lifetime? Or will it be more like a flu vaccine where a patient would need a yearly shot? If the vaccine needs a yearly dose to be effective, some future vaccines might not.


4 posted on 04/02/2021 8:21:11 AM PDT by SeekAndFind
[ Post Reply | Private Reply | To 2 | View Replies ]

To: SeekAndFind
So how come the French, the German , Italian and most EU governments banned the Pfizer vaccine and only lifted the ban just in the last week and some of those governments still ban certain age groups from taking Pfizer's covid vaccine?
7 posted on 04/02/2021 8:25:35 AM PDT by SmokingJoe
[ Post Reply | Private Reply | To 2 | View Replies ]

Free Republic
Browse · Search
General/Chat
Topics · Post Article


FreeRepublic, LLC, PO BOX 9771, FRESNO, CA 93794
FreeRepublic.com is powered by software copyright 2000-2008 John Robinson